Stocks making the biggest moves midday: Rivian, Tesla, Sandisk, Blue Owl, AeroVironment & more
Midday movers included Rivian, which rose 8% after raising its 2026 delivery outlook to 65,000–70,000 EVs (from 62,000–67,000). Tesla fell 8% despite Q2 deliveries of 480,126 vs 406,600 expected. U.S. CMS proposed a 2.4% 2027 hospital/ambulatory rate increase, lifting UHS 7% and HCA 5%. KeyBanc initiated Waystar at overweight with a $30 target. Alphabet fell ~2% after a European antitrust case upheld a €4.1B fine.
How this was made
The 30-second read
Why it matters
The most tradable items are primary catalysts with concrete figures: Rivian’s 2026 delivery range raise, AeroVironment’s $500M Army contract, CMS’s proposed 2027 hospital/ASC rate increase, and Blue Owl’s redemption-pressure update. Several other moves are analyst-driven (KeyBanc initiation, D.A. Davidson upgrade, Mizuho PT hike) or driven by sector/crypto price action (memory selloff, BTC > $61k).
Market read
Traders can act on same-day repricing from guidance/contract/regulatory-policy catalysts, while analyst/crypto/sector-driven moves may require tighter risk management due to potential reversals.
What to watch
For Tesla and memory names, the article lacks the specific “why” behind the market reaction (quality of deliveries, margins, or DRAM/NAND pricing), which can dominate follow-through beyond the headline numbers.
Background
This is a midday market wrap highlighting multiple movers across healthcare reimbursement policy, EV delivery outlooks, private credit redemption dynamics, defense contracting, and crypto-linked price action.
Ticker impact
Rivian shares jumped 8% after it raised its 2026 delivery outlook to 65,000–70,000 from 62,000–67,000.
Near-term upside bias as traders reprice 2026 volume expectations; follow-through depends on margin/ASP commentary not provided here.
The article provides a concrete guidance revision and same-day move, but lacks profitability or demand detail to gauge magnitude beyond deliveries.
Tesla slid 8% even after reporting Q2 deliveries of 480,126, above StreetAccount’s 406,600 estimate.
Choppy/negative near-term as the market discounts the beat; direction likely hinges on what the market inferred beyond the headline delivery count.
The article gives the beat vs consensus and the same-day drop, but does not specify the market’s exact reason for selling.
Universal Health Services rose 7% after CMS proposed a 2.4% 2027 payment-rate increase for hospitals and ambulatory surgical centers.
Supportive bias for the stock while the CMS proposal remains the dominant catalyst; magnitude depends on final rulemaking.
The article ties the move to a specific CMS proposal and rate change, but it’s still a proposal rather than final guidance.
HCA Healthcare gained 5% on the same CMS proposal calling for a 2.4% 2027 payment-rate increase.
Mild-to-moderate upside bias near term as traders price in incremental reimbursement; could fade if details change in the final rule.
Direct linkage between the CMS proposal and the stock move, but the article doesn’t quantify sensitivity or finalization timeline.
Blue Owl’s stock jumped more than 4% after a shareholder letter said redemption pressure is easing for its private credit funds.
Potential continuation higher if investors believe the redemption trend is durable; watch for whether withdrawals stay within the 5% cap.
The article provides specific redemption-flow figures and a stated withdrawal-cap policy, but not performance/credit-loss details.
Waystar Holding rose 9% after KeyBanc initiated coverage at overweight with a $30 price target.
Near-term upside bias while the upgrade/target narrative attracts incremental buyers.
The article includes the initiation, target, and thesis that AI disruption fears are overblown, but no new fundamentals beyond the analyst view.
AeroVironment gained 11% after winning a $500 million U.S. Army contract to develop counter-drone capabilities.
Likely positive follow-through as traders incorporate backlog/revenue contribution; magnitude depends on margin and program duration not provided here.
The contract size and purpose are explicit and are typically material for defense contractors; the catalyst is primary and same-day.
Palantir jumped 3% after D.A. Davidson upgraded it to buy from neutral and called valuation the most attractive in some time.
Moderate upside bias near term; follow-through depends on whether broader market sentiment supports growth/AI names.
The article provides the upgrade and valuation thesis but no new company-specific operational data.
Market effects
Healthcare services outperformance is tied to CMS proposed reimbursement changes; memory weakness reflects broader profit-taking in DRAM/NAND.
EU antitrust upheld for Alphabet adds regulatory risk premium for large platform/ads ecosystems.
Defense contract award supports U.S. defense spending sentiment; crypto-linked moves (BTC > $61k) spill into exchange/broker sentiment.
Counterpoint
Some single-stock moves (e.g., Apple momentum, crypto-linked rallies) may fade if the underlying driver is sector/price-action rather than new fundamentals.
Key entities
- companyRivian Automotive
Raised its 2026 delivery outlook range to 65,000–70,000 EVs.
- companyTesla
Reported Q2 deliveries of 480,126 but shares fell 8%.
- companyUniversal Health Services
Shares rose 7% on CMS proposed 2027 payment-rate increase.
- companyHCA Healthcare
Shares rose 5% on the same CMS proposed 2027 payment-rate increase.
- companyBlue Owl Capital
Stock jumped as a shareholder letter said redemption pressure is easing.
